As of my last update in October 2023, there is limited publicly available information regarding the chemical substance identified as LSN3353871 with the CAS number 2565657-20-5. Typically, substances with such identifiers are often in the research or development phase, possibly related to pharmaceutical or biochemical applications. Characteristics of such compounds may include their molecular structure, functional groups, solubility, stability, and biological activity, which are crucial for understanding their potential uses and effects. For specific details such as physical properties, synthesis methods, or biological interactions, consulting scientific literature, databases, or proprietary sources would be necessary. Additionally, safety data sheets (SDS) and regulatory filings may provide insights into handling, toxicity, and environmental impact. If you are looking for specific characteristics or applications, I recommend checking specialized chemical databases or publications for the most accurate and detailed information.

LSN3353871

2565657-20-5: As of my last update in October 2023, there is limited publicly available information regarding the chemical substance identified as LSN3353871 with the CAS number 2565657-20-5. Typically, substances with such identifiers are often in the research or development phase, possibly related to pharmaceutical or biochemical applications. Characteristics of such compounds may include their molecular structure, functional groups, solubility, stability, and biological activity, which are crucial for understanding their potential uses and effects. For specific details such as physical properties, synthesis methods, or biological interactions, consulting scientific literature, databases, or proprietary sources would be necessary. Additionally, safety data sheets (SDS) and regulatory filings may provide insights into handling, toxicity, and environmental impact. If you are looking for specific characteristics or applications, I recommend checking specialized chemical databases or publications for the most accurate and detailed information.

<p>LSN3353871 is a highly potent and orally available lipoprotein a [Lp(a)] inhibitor (IC50 = 1.69 µM) that binds to Kringle IV (KIV),cardiovascular diseases.</p>

CAS 2565657-20-5

LSN3353871

LSN3353871

Ref: 54-BUP21461

LSN3353871

Ref: TM-T88199